News & Perspective

May 03, 2019

May 03, 2019

News Scan for May 03, 2019

WHO H5N1 flu confirmation
Carbapenem reduction strategy
More polio in Afghanistan, Pakistan
Flu imprinting research
Mayaro virus in South America

Apr 18, 2019

Apr 18, 2019

News Scan for Apr 18, 2019

Measles resurgence
Serious cervical lesions in US
H5N6 in Cambodian poultry

Nov 06, 2017

Nov 06, 2017

News Scan for Nov 06, 2017

Strep burden, resistance threat
Salmonella probe ends
Ebola susceptibility
MDR-TB in Minnesota

Aug 19, 2015

Aug 19, 2015

News Scan for Aug 19, 2015

More Cyclospora cases
Plague in California
Ricin vaccine funding

Aug 16, 2018

Aug 16, 2018
Aedes aegypti closeup

Study profiles local Zika threat to California; first live attenuated vaccine trial begins

In another new development, the NIH today announced the start of the first human trial of a live attenuated vaccine against Zika.

Jun 20, 2017

Jun 20, 2017
Aedes aegypti mosquito

Data on Zika in mosquitoes suggest early presence in Rio

A separate study found Zika virus in the saliva of 5 different mosquito species in Mexico.

Feb 05, 2013

Feb 05, 2013

NIH launches trio of trials seeking better flu treatments

(CIDRAP News) – Three large, multi-center studies now in the enrollment stage will assess whether such approaches as a combination of antiviral drugs or the use of borrowed antibodies can improve on existing treatments for influenza, the National Institutes of Health (NIH) announced today.

Dec 11, 2009

Dec 11, 2009

New vaccine technologies on horizon but face roadblocks

(CIDRAP News) – New ways of producing influenza vaccine that would free the process from long-standing problems are on the horizon, federal officials said today, but they added that scientific and regulatory hurdles will slow the products' movement past licensure and into the market.

Apr 29, 2009

Apr 29, 2009

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»